ClinicalTrials.gg
Enrolling by invitationNCT07304037Updated Dec 26, 2025

The Effect of Skin-to-Skin Contact Applied in the Early Postpartum Period on Maternal Pain, Birth Satisfaction, and Maternal Vital Signs Dynamics

An interventional study of A solid hour of skin-to-skin contact in Maternal Vital Signs, Skin-to-skin Contact and Birth Satisfaction, sponsored by Istanbul University - Cerrahpasa. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-26.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled May 2025, registered Dec 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Labor Pain by Istanbul University - Cerrahpasa — 3 open to participants now, 4 under way, none of them phase 3. Labor Pain · Istanbul University - Cerrahpasa.

Started
2025
with 3 others
No phase
9 of 10
3 open now
Registered
8th of 10
by date

Among the 10 studies in Labor Pain by Istanbul University - Cerrahpasa, this one is one of 4 that started in 2025, is one of 9 with no phase, and was the 8th registered.

Labor Pain

426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.

Browse Labor Pain studies →

Open to participants now

3 of the 10 studies in Labor Pain by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Labor Pain by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

Skin-to-skin contact (STSC) initiated within the first hour after birth is a fundamental practice that supports both the mother's and the newborn's physiological and psychological adaptation (Çelik \& Kök, 2022). The World Health Organization recommends at least 90 minutes of uninterrupted SKC immediately after birth and defines this practice as a mandatory component of care under the Baby-Friendly Hospital Initiative (World Health Organization, 2024; Abdulghani et al., 2018; Sharma, 2016). The positive effects of TTT on maintaining the newborn's temperature, glucose regulation, physiological stability, and mother-infant bonding have been proven (Sezici \& Yiğit, 2020; Safar et al., 2018). In addition, it has been reported that it can shorten the third stage of labor by increasing maternal oxytocin release and reduce maternal stress and anxiety (Püsküllüoğlu et al., 2022; Harati Kabir et al., 2024).

In the study, mothers in the intervention group will receive one hour of uninterrupted TTT immediately after delivery; routine midwifery care will continue in the control group. In both groups, maternal pain levels, birth satisfaction, and vital signs (body temperature, oxygen saturation, heart rate, and blood pressure) will be assessed immediately after delivery, and at 30, 60, and 90 minutes.

The sample size was calculated using GPower, and a total of 68 participants (34 in each group) will be included in the study. Inclusion criteria include women aged 18 years or older who have had a full-term vaginal delivery and have a single, uncomplicated pregnancy. The data collection tools used will be the Demographic Information Form and the Visual Analog Scale (VAS).

The findings of the study are expected to enhance the quality of midwifery care by supporting the integration of TTT into clinical practice in early postpartum care.

Read the detailed description

H1: There is a difference in pain scores measured using the Visual Analog Scale (VAS) between the group that received uninterrupted skin-to-skin contact for one hour after birth and the control group immediately after birth, at 30, 60, and 90 minutes.

H1: There is a difference in birth satisfaction scores measured using the Visual Analog Scale (VAS) between the group that received uninterrupted skin-to-skin contact for one hour after birth and the control group immediately after birth, at 30, 60, and 90 minutes.

H1: There is a difference between the group that received uninterrupted skin-to-skin contact for one hour after birth and the control group in terms of maternal body temperature, oxygen saturation, heart rate, and blood pressure measurements taken immediately after birth and at 30, 60, and 90 minutes.

03

Conditions studied

  • Maternal Vital Signs
  • Skin-to-skin Contact
  • Birth Satisfaction

Browse trials for

Keywords

  • maternal vital signs
  • skin-to-skin contact
  • birth satisfaction
  • Maternal outcomes
  • labor pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntarily agree to participate in the study
  • Be able to read, understand, and write in Turkish
  • Be 18 years of age or older
  • Have given birth vaginally
  • Have given birth to a single baby
  • Be at term (between 38-42 weeks of gestation)
  • Have given birth vaginally in vertex presentation
  • Estimated fetal weight between 2500-4000 grams
  • Not having received any analgesia or anesthesia to relieve pain and fatigue during labor
  • Having a pregnancy without maternal or fetal complications

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancies
  • High-risk pregnancies with complications
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
68 participants (estimated)

Study arms

  • Experimental
    Experimental Group

    Immediately after birth, skin-to-skin contact is maintained continuously for one hour. Pain levels, birth satisfaction levels, and maternal vital signs (body temperature, oxygen saturation, heart rate, and blood pressure) are assessed at 30, 60, and 90 minutes postpartum.

    Procedure: A solid hour of skin-to-skin contact

  • No intervention
    Control Group

    Following delivery, routine midwifery care is provided, and immediately after birth, at 30, 60, and 90 minutes, pain levels, satisfaction with the birth, and maternal physiological findings (body temperature, oxygen saturation, heart rate, and blood pressure) are assessed.

Interventions

  • ProcedureA solid hour of skin-to-skin contact

    Immediately after birth, skin-to-skin contact is maintained for one hour without interruption. Pain levels, birth satisfaction levels, and maternal vital signs (body temperature, oxygen saturation, heart rate, and blood pressure) are assessed at 30, 60, and 90 minutes postpartum.

06

What researchers measure

Primary outcomes

  1. Visuel Analog Scale -Pain

    Min: 0- Max:10

    Time frame: At 30, 60, and 90 minutes after birth

  2. Visuel Analog Scale- Birth satisfaction

    Min:0-Max:10

    Time frame: At 30, 60, and 90 minutes after birth

07

Study locations

1 site
08

References and documents

Publications

  • Abdulghani N, Edvardsson K, Amir LH. Worldwide prevalence of mother-infant skin-to-skin contact after vaginal birth: A systematic review. PLoS One. 2018 Oct 31;13(10):e0205696. doi: 10.1371/journal.pone.0205696. eCollection 2018. PubMed 30379859 ↗
  • Sharma A. Efficacy of early skin-to-skin contact on the rate of exclusive breastfeeding in term neonates: a randomized controlled trial. Afr Health Sci. 2016 Sep;16(3):790-797. doi: 10.4314/ahs.v16i3.20. PubMed 27917213 ↗
  • Safari K, Saeed AA, Hasan SS, Moghaddam-Banaem L. The effect of mother and newborn early skin-to-skin contact on initiation of breastfeeding, newborn temperature and duration of third stage of labor. Int Breastfeed J. 2018 Jul 16;13:32. doi: 10.1186/s13006-018-0174-9. eCollection 2018. PubMed 30026787 ↗
  • Kabir FH, Razavinia F, Keshavarz M, Mousavi SS, Haghani H. Effect of Companion Presence during Skin-to-Skin Contact on Maternal Anxiety: A Randomized Clinical Trial. Indian Pediatr. 2024 Mar 15;61(3):230-236. PubMed 38469838 ↗
  • Püsküllüoğlu, B., Göker, A. & Kosova, F. The effect of skin-to-skin contact on the expulsion time of the placenta and delivery hormones. DEU Tıp Dergisi, 2022, 36(3), 237-242. https://doi.org/10.18614/deutip1230581
  • Sezici E, Yigit D. The Effect of Skin-to-Skin Contact on Maternal Anxiety, Heart Rate, and Oxygen Saturation during the Vaccination of One-Month-Old Infants. Compr Child Adolesc Nurs. 2020 Dec;43(4):410-420. doi: 10.1080/24694193.2020.1721614. Epub 2020 Feb 19. PubMed 32073934 ↗
  • Çelik, İ. & Kök, G. Examination of nurses' and midwives' knowledge and attitudes regarding early skin-to-skin contact between mother and newborn. Istanbul Development University Journal of Health Sciences, 2022, 17, 558-574.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in May 2025, 0 months.

Of 192 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's 0 months is below that.

Counting every sponsor, half of 194 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2025
First posted
Dec 26, 2025
StartActual
May 12, 2025
Primary completionActual
May 13, 2025
CompletionEst.
Apr 15, 2026
Last update
Dec 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07304037
Responsible party
Yasemin Dincel (Researcher Assistant, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Dec 26, 2025
Start date
May 12, 2025
Primary completion
May 13, 2025
Completion
Apr 15, 2026 (estimated)
Last update
Dec 26, 2025

Study contacts

Yasemin Dinçel
principal investigator · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion